pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 28·1 min read
save

Former Legend Biotech co‑founder Frank Fan launches new venture at Wondercel Therapeutics

May 28, 2026·read at Endpoints ↗Positive

Frank Fan, a co‑founder of Legend Biotech, moved from Nanjing to Shenzhen in 2022 in search of a fresh start.

After leaving Legend abruptly, he assumed the role of chief executive officer at Wondercel Therapeutics.

Fan says he is ready to showcase the company’s next project, marking a new chapter for both himself and the firm.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “#ASCO26: After leaving Legend, Frank Fan is ready to showcase his next project”

read at Endpoints ↗
92 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Legend Biotech Corp2
topics
CAR-T

related stories

  • Sep 25J&J, Legend tout long-term survival benefits for Carvykti in multiple myelomaBioSpace
  • Sep 239 companies hiring in Pennsylvania nowBioSpace
  • Sep 17Chutes & Ladders—Legend poaches Novartis vet to boost commercial potentialFierce Biotech
  • Sep 8Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpointFierce Biotech
  • Sep 3The hidden scale-out problem behind CAR-T’s growthBioPharma Dive